The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The real-world data in patients with advanced gastric cancer treated with ramucirumab combination chemotherapy.
 
Akie Kimura
No Relationships to Disclose
 
Daisuke Sakai
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Toshihiro Kudo
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer Yakuhin
Research Funding - Bayer Yakuhin; Chugai Pharma; Lilly; Ono Pharmaceutical; Yakult Honsha
 
Naohiro Nishida
No Relationships to Disclose
 
Aya Katou
No Relationships to Disclose
 
Chiaki Inagaki
No Relationships to Disclose
 
Toru Otsuru
No Relationships to Disclose
 
Koji Tanaka
No Relationships to Disclose
 
Yasuhiro Miyazaki
No Relationships to Disclose
 
Tomoki Makino
No Relationships to Disclose
 
Tsuyoshi Takahashi
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Medtronic; MSD; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
 
Makoto Yamasaki
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose
 
Masaki Mori
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Astellas Pharma; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck; Merck Serono; Ono Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)